Our work on neuroblastoma cells show that targeting ATP13A3, a polyamine transporter, with the inhibitor AMXT 1501 or gene silencing, combined with difluoromethylornithine treatment, effectively inhibits neuroblastoma cell growth. The gene discussed is ATP13A3; the disease is neuroblastoma.